References
- McCarbergBHArgoffCETopical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injuryInt J Clin Pract201064111546155320666849
- BookmanAAWilliamsKSShainhouseJZEffect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trialCMAJ2004171433333815313991
- StanosSPTopical agents for the management of musculoskeletal painJ Pain Symptom Manage200733334235517349504
- LionbergerDRBrennanMJTopical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patchJ Pain Res2010322323321197326
- PetersenBRovatiSDiclofenac epolamine (Flector) patch: evidence for topical activityClin Drug Investig200929119
- RainsfordKDKeanWFEhrlichGEReview of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamineCurr Med Res Opin200824102967299218814824
- GalerBSRowbothamMPeranderJDeversAFriedmanETopical diclofenac patch relieves minor sports injury pain: results of a multi-center controlled clinical trialJ Pain Symptom Manage200019428729410799795
- LionbergerDRJoussellinELanzarottiAYanchickJMagelliMDiclofenac epolamine topical patch relieves pain associated with ankle sprainJ Pain Res20114475321559350
- BanningMTopical diclofenac: clinical effectiveness and current uses in osteoarthritis of the knee and soft tissue injuriesExpert Opin Pharmacother20089162921292918937623
- QvistMHHoeckUKreilgaardBMadsenFFrokjaerSEvaluation of Göttingen minipig skin for transdermal in vitro permeation studiesEur J Pharm Sci2000111596810913754
- BansalSDeStefanoAKey elements of bioanalytical method validation for small moleculesAAPS J200791E109E11417408234
- ShahVPMidhaKKFindlayJWBioanalytical method validation – a revisit with a decade of progressPharm Res200017121551155711303967
- ViswanathanCTBansalSBoothBQuantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assaysPharm Res200724101962197317458684
- Food and Drug AdministrationGuidance for Industry: Bioanalytical Method ValidationUS Department of Health and Human Services, FDA, Center for Drug Evaluation and Research2001 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdfAccessed June 5, 2012
- GibaldiMPerrierDPharmacokineticsNew YorkMarcel Dekker Inc1975
- OberleRLDasHWongSLChanKKSawchukRJPharmacokinetics and metabolism of diclofenac sodium in Yucatan miniature pigsPharm Res19941156987038058639
- BodeGClausingPGervaisFfor Steering Group of the RETHINK ProjectThe utility of the minipig as an animal model in regulatory toxicologyJ Pharmacol Toxicol Methods201062319622020685310
- GschwendMHMartinWArnoldPDetermination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparationArzneimittelforschung200555740341316080280
- HeynemanCALawless-LidayCWallGCOral versus topical NSAIDs in rheumatic diseases: a comparisonDrugs200060355557411030467
- SinghPRobertsMSSkin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical applicationJ Pharmacol Exp Ther199426811441518301551
- FiniAFazioGGonzalez-RodriguezMCavallariCPasseriniNRodriguezLFormation of ion-pairs in aqueous solutions of diclofenac saltsInt J Pharm1999187216317310502622
- JenourePSegesserBLühtiUGremionGA trial with diclofenac HEP plaster as topical treatment in minor sport injuriesDrugs Exp Clin Res19931931251318112201